It therefore seems likely that IL-1β, IL-6 and possibly CRP activity after critical illness perpetuate vascular dysfunction and cardiovascular disease just as they do in the outpatient setting, and this is likely a consequence of ongoing processes linked to cell stress, inflammatory cell death and the engagement of a disease tolerance programme. This evidence concerns the gene CRP and cardiovascular disorder.